DV
Dividend Vision

FLGT — Fulgent Genetics, Inc.

Fulgent Genetics, Inc. (FLGT)

Total return is 102.2% over the past 9.9 years, 220.2 points behind SPY at 322.4%. Its deepest 1-year drawdown was 55.3%.

FLGT is an equity stock that operates in the genetic testing and diagnostics sector. As a single-stock holding rather than a diversified fund, it does not generate a dividend distribution yield and carries no fund-level expense ratio. This security appeals to investors seeking exposure to genomics and personalized medicine companies rather than traditional income-focused portfolios.

FLGT key facts

Asset type
Stock
Asset class
Equity
Inception date
09/29/2016
Distribution frequency
None
Last close
$18.56
Market cap
$510,683,808
Average volume
140468.0
Beta
0.905
Payout ratio
0.0
Forward P/E
7.7042
EPS
$-2.83